Tropical Spastic Paraparesis Market: Overview
Tropical spastic paraparesis (TSP) also called as HTLV-1–associated myelopathy (HAM) is a type of tropical myeloneuropathies caused by the human T-lymphotrophic virus 1 (HTLV-1). Although initially described in tropical countries, TSP has also been found in temperate regions such as southern Japan. HTLV-1 virus belongs to the Retroviridae family, and preferentially infects CD4 lymphoid cells. The virus has been known to cause certain kinds of leukemia and lymphoma and is transmitted through exposure to infected blood, sexual contact, and use of illegal intravenous drugs. As the virus is also known to spread through breast milk, mothers infected with HTLV-1 virus must avoid breast feeding.
According to an article published in the journal Frontiers in Microbiology in 2012, the HTLV-1 virus is prevalent in certain regions including the Southwestern part of Japan, sub-Saharan Africa and South America, the Caribbean area, and certain areas of Middle East and Australo-Melanesia. The study also estimates that 5 million to 10 million individuals have been affected globally with HTLV1 virus, however various other publications estimate the global prevalence of 10 million to 20 million.
HTLV-1-associated myelopathy mostly affects the spinal cord, and results in an upper motor neurone syndrome, that usually affects lower limbs. Spastic paraparesis or paraplegia is the main characteristic of the infection. Tropical spastic paraparesis results in demyelination, inflammation and necrotic lesions in spinal cord. The progressive disease is associated with degeneration of neurons in the spinal cord, and results in gradual paralysis of the lower limbs. Other rare symptoms include optic atrophy, reduced ankle reflex and cranial nerve lesions. An article published in journal Revue Neurologique in 2012, more than 90% of the tropical spastic paraparesis cases, the neurological features involved urinary bladder disturbance, spasticity and/or hyperreflexia of the lower extremities, and lower extremity muscle weakness.
Tropical Spastic Paraparesis Market: Product and Treatment Landscape
Various immunoassay kits are available for diagnosis of HTLV-1 virus. Companies manufacturing such diagnostic kits include MP Biomedicals LLC, Fujirebio, Inc., Quest Diagnostics, DiaSorin S.p.A. Although the disease cannot be cured completely, medications are available for management of symptoms. Corticosteroids such as methylprednisolone are prescribed to decrease the inflammation of the spinal cord, while pain is treated with non-steroidal anti-inflammatory medications.
Symptoms of urinary dysfunction can be treated by prescribing darifenacin, oxybutynin, tamsulosin, terazosin, and other drugs which reduce the activity of bladder muscles. National Institute of Neurological Disorders and Stroke (NINDS) is currently conducting phase I clinical trials for Hu MiK-Beta-1. The investigational drug is monoclonal antibody directed toward IL-2/IL-15R-Beta Subunit which blocks IL-15 action. Washington University School of Medicine in association with Merck Sharp & Dohme Corp. is also conducting phase II trials for Raltegravir. Various other institutes are also conducting research programs for discovering new and effective treatment options for Tropical spastic paraparesis. Scientists have also tried antiretroviral agents for treatment of HTLV-1 infections. Gradual progress in the research activities is expected to launch more treatment drugs and expand the market in the future.
Due to low and restricted geographical prevalence of the disease, the market for tropical spastic paraparesis is small. Government initiative for increasing awareness of the disease and its available treatment may curb the spread of infections. Lack of sufficient information on geographical prevalence, and epidemiology has restricted the research activities. These factors will also be responsible for a slower global market growth.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.